⭐ Webinar Pre-registration (Click) ⭐ * We are pleased to announce the 5th C&R Webinar, taking place on April 29. Under the theme,'Beyond Response: How MRD is Transforming Cancer Treatment and Drug Development',this webinar will explore the scientific significance of MRD in line with the latest regulatory trends,as well as the evolving strategies in clinical development. Join our Medical Advisors, Dr. Yongju Chung and Dr. Eunsoo Lim,for an insightful session offering strategic perspectives to enhance the probability of success in clinical trials. * [Session 1]✔ Topic: MRD, the Invisible Signal of Cancer: Scientific Insights and Clinical Value✔ Speaker: Dr. Yongju Chung – Medical Advisor (MD, Pharmacist)[Session 2]✔ Topic: A Turning Point in Multiple Myeloma Drug Development:Accelerated Approval Strategies under FDA MRD Draft Guidance✔ Speaker: Dr. Eunsoo Lim – Medical Advisor (MD, Internal Medicine Specialist) 

  C&R Reporter brings you the latest updates from C&R Research.C&R Research is expanding its global clinical networkacross Asia as an Asian Global CRO.With the establishment of its Indonesia office,C&R Research is further enhancing clinical operations across the ASEAN region.What defines C&R Research’s Asian Global CRO strategy?Let’s explore C&R Research’s Asia-focused clinical strategy.  Q. What is C&R Research's Asian Global CRO strategy?A. It is a CRO that connects Asia to global clinical trials.• Deep understanding of local regulations and clinical environments • MRCTs enabled through cross-country collaboration• Integrated clinical operations across diverse populations and dataThis strategy expands Asia into an integrated clinical hub beyond single-country operations.     Q. Why is Indonesia a key focus for C&R Research?A. Indonesia is a key market for expanding clinical trials across the ASEAN region. • Growing demand for MRCTs from global pharmaceutical companies • Rapidly expanding clinical trial landscape in ASEAN• A population of 280M with diverse population characteristicsIndonesia continues to play a key role in clinical research across ASEAN.Q. What has changed with the establishment of the Indonesia office?A. C&R Research is expanding its clinical operations across Asia through its Indonesia office.• Stronger clinical collaboration between Korea and ASEAN • Expanded MRCT capabilities across the ASEAN region• Integrated operations with existing global affiliatesThis supports more flexible and efficient global clinical trial management.C&R Research is expanding its clinical capabilities across Asia through its Indonesia office.Integrated regional operations strengthen multi-regional clinical trial capabilities.As an Asian Global CRO, C&R Research supports global clinical trials with stability and expertise.Learn more about C&R Research’s global clinical strategy on our website.Thank you for your continued interest in C&R Research.

 C&R Reporter is here to deliver clinical insights from C&R Research.The global clinical trial landscape is rapidly evolving.With the revision of ICH E6(R3) Good Clinical Practice, the core guideline for global clinical trials,new standards are being introduced across the entire clinical trial lifecycle. Recent global regulations are shifting clinical quality management from traditional operationaloversight toward a Risk-based Quality Management approach.C&R Research operates as an End-to-End CRO,partnering with sponsors in today’s evolving clinical environment.In this article, we explore the key updates of ICH GCP R3 andhow the role of CROs is evolving within the changing global regulatory landscape.  Q. Why is the ICH GCP R3 revision important for clinical trials?A. ICH E6(R3) Good Clinical Practice redefines quality managementby reflecting the realities of modern clinical trials.The revision emphasizes building quality into clinical trials from the design phase.Key concepts include: • Risk-based Quality ManagementProactive risk identification and management• Data ReliabilityEnsuring reliable and high-quality clinical data• Quality by DesignBuilding consistent quality from the earliest trial design stageThese principles emphasize structured management across the clinical development lifecycle.   Q. How is the role of CROs evolving under new global regulations?A. As global clinical regulations evolve, CROs are expanding beyond operational supporttoward comprehensive clinical development management. Clinical trials involve interconnected processes including development strategy, protocol design,clinical operations, data management, and statistical analysis. Ensuring quality and efficiency now requires an integrated,lifecycle-based approach rather than managing each phase independently.CROs are evolving into strategic partners managing the full clinical development processwhile ensuring global regulatory compliance.Q. How does C&R Research operate clinical trials?A. C&R Research supports the full clinical development lifecyclethrough an End-to-End clinical operating model.From early development planning to study completion,we build an integrated framework where every phase works seamlessly together.As an End-to-End CRO, C&R Research provides:• Clinical StrategyClinical development planning• Protocol DesignStudy protocol development• Regulatory AffairsGlobal regulatory strategy and submissions• Clinical OperationsTrial management and monitoring• Data ManagementClinical data management• BiostatisticsStatistical analysis and CSR preparationIn today’s rapidly changing global regulatory environment,connectivity across the clinical development lifecycle has become more important than ever.C&R Research delivers global-standard clinical trials as a trusted End-to-End CRO partner.Explore our integrated clinical development solutions on our website.Thank you for your continued interest in C&R Research.

 C&R Reporter is here to introduce C&R Research’s latest data-driven innovation.C&R Research is strengthening its capabilities as a specialized Data CROfocused on clinical data.Recently, in collaboration with Mediplexus,C&R Research launched a Hybrid Clinical Solutionconnecting clinical trial data with real-world data(RWD). Here’s what has changed.We introduce the C&R x MPX Hybrid Clinical Solutionand C&R Research’s Data CRO strategy.  Q. What is the C&R x MPX Hybrid Clinical Solution?A. It is a solution that integrates clinical trial data with hospital-based real-world data(RWD). • Mediplexus: Provides hospital EMR-based real-world data(RWD)• C&R Research: Provides data design, standardization, statistical analysis, and reportingBy integrating EMR-based real-world data with standardized research data,the solution generates regulatory-grade real-world evidence(RWE) for decision-making. This enables faster and more precise data-driven decisionsin Risk Management Plan(RMP) and pharmacovigilance research.    Q. How does C&R Research operate data-driven clinical trials?A. C&R Research operates through dedicated data teams. • Data Management: Data collection and management• Biostatistics: Statistical analysis• Medical Operation: RWD-based study planning and reporting• RWO: Clinical operation support From data generation → cleaning → analysis → reporting, C&R Research manages the entire process within one integrated system,ensuring data quality and consistency.Q. What differentiates C&R Research as a Data CRO?A. C&R Research is a specialized Data CRO that transforms data into actionable evidence.• Designs data for regulatory readiness• Implements data strategy across clinical development to post-authorization studies• Applies strategic data utilization in RWD∙RWE environmentsC&R Research is a Data CRO that transforms data from numbers into decision-ready evidence.C&R Research is a Data CRO that manages the full clinical data lifecyclefrom generation to regulatory application.As RWD and RWE expand,C&R Research remains a strategic clinical partner that turns data into value.Learn how C&R Research, a Data CRO,provides end-to-end clinical solutions by visiting our website.Thank you for your continued interest in C&R Research.

 C&R Reporter is here to show how we recharge and thrive at C&R Research. C&R Research is an End-to-End CRO with over 500 clinical experts,supporting the entire clinical process from planning to conduct, data management and reporting. To help our experts work sustainably and confidently, C&R Research offers special employee benefits.  Q. Where do you head first when you arrive at C&R Research?A. The first-floor lounge, featuring coffee, tea, and book lending. It’s where most staff naturally stop in the morning.Even the C&R Reporter starts the day here with a cup of coffee. Coffee and a variety of teas are available to start the day on a positive note. A bookshelf in the back offers book lending for staff leisure, with new titles shared every month.Q. What kinds of books are available?A. The lounge offers a variety of books,from pharmaceutical, biotech, and clinical references to hobby reads for leisure. On the first floor at C&R Research, staff can take a relaxing pause with these books.  Q. What kind of space is on the top terrace at C&R Research?A. The C&R Terrace, a sky garden for staff.It’s a place to enjoy the open sky and nature up close,perfect for a relaxing pause or a light discussion with colleagues.Q. What experiences are available at the C&R Terrace?A. The terrace features workshops, lunch, and relaxation for staff.It also hosts departmental events, and on sunny days, staff can enjoy lunch outdoors.It’s a unique and comfortable spot at C&R Research for recharging during the workday.Q. What unique benefits does C&R Research offer beyond its workspace facilities?A. Family Day and Lunch Day provide staff with flexible work hours and a free lunch.These special benefits give staff time,helping them naturally balance work and personal life.Q. How are Family Day and Lunch Day organized?A. Staff receive two early leaves and two free lunches each month.On Mondays, office staff can enjoy a free lunch,allowing them to focus on work without worrying about meals.On Fridays, staff work only in the morning and leave early,giving them a more relaxed afternoon.Q. What are the benefits of Family Day and Lunch Day?A. They help staff balance work and personal life, and enjoy time with colleagues.Twice a month, staff can manage personal schedules more flexibly and spend relaxed moments over a free lunch.Q. What is the biggest advantage of working at C&R Research?A. As an End-to-End CRO, we support work efficiency while providing clinical experts a stable work environment. C&R Research maintains a healthy balance between work and rest, so everyone can focus with ease.  Learn more about End-to-End CRO solutions at C&R Research on our website.We look forward to sharing more updates from C&R Research with you.